Wills Financial Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,705
Closed -$227K 59
2018
Q4
$227K Sell
1,705
-2,330
-58% -$382K 0.17% 56
2018
Q3
$768K Sell
4,035
-267
-6% -$49K 0.51% 45
2018
Q2
$717K Sell
4,302
-1,805
-30% -$290K 0.52% 45
2018
Q1
$1.03M Sell
6,107
-214
-3% -$35.9K 0.76% 39
2017
Q4
$1.03M Sell
6,321
-455
-7% -$81.6K 0.72% 41
2017
Q3
$1.39M Buy
6,776
+1,590
+31% +$370K 1.02% 36
2017
Q2
$1.26M Buy
5,186
+992
+24% +$233K 0.94% 39
2017
Q1
$1M Buy
4,194
+1,874
+81% +$436K 0.77% 39
2016
Q4
$487K Buy
+2,320
New +$481K 0.4% 49

Other funds holding AGN

Wills Financial Group's AGN Position: Q1 2019 in Review

Wills Financial Group sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 1,705 shares — an estimated $227K sold.

Wills Financial Group first reported a position in AGN in Q4 2016 and held it in 9 quarters. The position peaked at $1.39M in Q3 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Wills Financial Group reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Wills Financial Group sold 1,705 Allergan plc shares in Q1 2019, an estimated $227K.
  • Wills Financial Group first reported a position in Allergan plc in Q4 2016 and held it in 9 quarters.
  • Wills Financial Group's Allergan plc position peaked at $1.39M in Q3 2017.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Wills Financial Group's 13F filing for Q1 2019, filed 14 May 2019.